[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.12.79. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

December 2019 - January 1920

Decade

Year

Issue

December 2019, Vol 155, No. 12, Pages 1333-1436

In This Issue of JAMA Dermatology

Highlights

Abstract Full Text
free access
JAMA Dermatol. 2019;155(12):1333. doi:10.1001/jamadermatol.2018.3548
Viewpoint

Eliminating Copayments for Skin Cancer Screening—A Public Health Policy With Insufficient Evidence

Abstract Full Text
free access
JAMA Dermatol. 2019;155(12):1339-1340. doi:10.1001/jamadermatol.2019.2797

This Viewpoint argues against passage of legislation in Illinois that would eliminate copayments for skin cancer screening.

Editorial

Stripping Away Barriers to Find Relevant Skin Biomarkers for Pediatric Atopic Dermatitis

Abstract Full Text
JAMA Dermatol. 2019;155(12):1342-1343. doi:10.1001/jamadermatol.2019.2792

Natural Does Not Mean Safe—The Dirt on Clean Beauty Products

Abstract Full Text
free access has audio
JAMA Dermatol. 2019;155(12):1344-1345. doi:10.1001/jamadermatol.2019.2724

When Prevention Works, Nothing Happens

Abstract Full Text
JAMA Dermatol. 2019;155(12):1346-1347. doi:10.1001/jamadermatol.2019.2680
Original Investigation

Association of Lifetime Indoor Tanning and Subsequent Risk of Cutaneous Squamous Cell Carcinoma

Abstract Full Text
free access
JAMA Dermatol. 2019;155(12):1350-1357. doi:10.1001/jamadermatol.2019.2681

This cohort study examines whether there is a dose-response association between lifetime indoor tanning and risk of cutaneous squamous cell carcinoma.

Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis

Abstract Full Text
free access
JAMA Dermatol. 2019;155(12):1358-1370. doi:10.1001/jamadermatol.2019.2983

This cross-sectional study examines whether tape strips might be used to detect immune and barrier abnormalities and to define biomarkers associated with atopic dermatitis in children younger than 5 years with early-onset atopic dermatitis.

Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical Trial

Abstract Full Text
open access
JAMA Dermatol. 2019;155(12):1371-1379. doi:10.1001/jamadermatol.2019.2855

This randomized clinical trial investigates the efficacy and safety of once-daily oral abrocitinib, a Janus kinase 1 selective inhibitor, for patients with moderate to severe atopic dermatitis.

Decision-Analytic Modeling for Time-Effectiveness of the Sequence of Induction Treatments for Moderate to Severe Plaque Psoriasis

Abstract Full Text
JAMA Dermatol. 2019;155(12):1380-1389. doi:10.1001/jamadermatol.2019.2941

This time-effectiveness analysis assesses the cost-effectiveness of different sequences of induction treatment currently licensed in Germany for moderate to severe plaque psoriasis.

Association of Psoriasis With the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Dermatol. 2019;155(12):1390-1403. doi:10.1001/jamadermatol.2019.3056

This systematic review and meta-analysis of 58 observational studies assessed the risks of cancer incidence and mortality among people with psoriasis.

Factors Associated With Complete Remission After Rituximab Therapy for Pemphigus

Abstract Full Text
has audio
JAMA Dermatol. 2019;155(12):1404-1409. doi:10.1001/jamadermatol.2019.3236

This cohort study evaluates the association between use of rituximab and remission in patients with pemphigus.

Editor's Note

Understanding the Consequences of Eliminating Copayments for Skin Cancer Screening

Abstract Full Text
JAMA Dermatol. 2019;155(12):1341. doi:10.1001/jamadermatol.2019.3740
Review

A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018: A Systematic Review

Abstract Full Text
has active quiz
JAMA Dermatol. 2019;155(12):1410-1415. doi:10.1001/jamadermatol.2019.3064

This review highlights important original investigations on medical overuse in dermatology from 2017 to 2018.

Images in Dermatology

Pediculosis Pubis

Abstract Full Text
JAMA Dermatol. 2019;155(12):1416. doi:10.1001/jamadermatol.2019.2718

This case report describes a man in his 90s who presented with adherent brown concretions along the terminal hairs of his groin and scattered erythematous macules and papules on the underlying pubic skin and was diagnosed with pediculosis pubis.

Photosensitivity in Cutaneous Lupus

Abstract Full Text
JAMA Dermatol. 2019;155(12):1417. doi:10.1001/jamadermatol.2019.2769

This case report describes a woman in her 20s with systemic lupus erythematosus who presented with a cutaneous eruption on her face, ears, and breasts.

JAMA Dermatology Clinicopathological Challenge

Periumbilical Papules in a Middle-aged Woman

Abstract Full Text
has active quiz
JAMA Dermatol. 2019;155(12):1418-1419. doi:10.1001/jamadermatol.2019.2963

An obese woman in her 50s presented with mildly pruritic coalescent yellowish papules around the umbilicus. What is your diagnosis?

Asymptomatic Infiltrated Erythematous Skin Patch on the Breast

Abstract Full Text
has active quiz
JAMA Dermatol. 2019;155(12):1420-1421. doi:10.1001/jamadermatol.2019.3273

A woman in her early 80s presented with a 6-month history of an asymptomatic, enlarging, partly infiltrated erythematous cutaneous patch localized to the periareolar area of her left breast. What is your diagnosis?

Research Letter

Prevalence of Pemphigoid as a Potentially Unrecognized Cause of Pruritus in Nursing Home Residents

Abstract Full Text
JAMA Dermatol. 2019;155(12):1423-1424. doi:10.1001/jamadermatol.2019.3308

This cross-sectional study of 125 residents of 7 nursing homes in the Netherlands evaluates the prevalence of pemphigoid as a potentially unrecognized cause of pruritus.

Observation

Treatment of Pityriasis Rubra Pilaris With Guselkumab

Abstract Full Text
JAMA Dermatol. 2019;155(12):1424-1426. doi:10.1001/jamadermatol.2019.2774

This case report describes 2 patients with suberythrodermic pityriasis rubra pilaris treated with guselkumab.

Treatment of Refractory Chronic Pruritus of Unknown Origin With Tofacitinib in Patients With Rheumatoid Arthritis

Abstract Full Text
JAMA Dermatol. 2019;155(12):1426-1428. doi:10.1001/jamadermatol.2019.2804

This case report describes a series of patients with refractory chronic pruritus of unknown origin and rheumatoid arthritis who were treated with tofacitinib.

Comment & Response

HLA Screening for Dapsone Hypersensitivity in India—A Long Way Ahead

Abstract Full Text
JAMA Dermatol. 2019;155(12):1428-1429. doi:10.1001/jamadermatol.2019.3169

HLA Screening for Dapsone Hypersensitivity in India—A Long Way Ahead—In Reply

Abstract Full Text
JAMA Dermatol. 2019;155(12):1429. doi:10.1001/jamadermatol.2019.2609
Correction

Error in the Author Affiliations

Abstract Full Text
free access
JAMA Dermatol. 2019;155(12):1429. doi:10.1001/jamadermatol.2019.3279
JAMA Dermatology Patient Page

Measles

Abstract Full Text
free access
JAMA Dermatol. 2019;155(12):1436. doi:10.1001/jamadermatol.2019.2663

This Patient Page describes the risk factors for measles, symptoms of the disease, and methods of prevention and treatment.

JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2019;155(12):1335. doi:10.1001/jamadermatol.2018.3549
×